Focused Sessions – Block III of V

Concurrent Events

• 09:10 AM - 09:50 AM

  Cybersecurity, Privacy and Resilience in AI Age | Pitfalls to Avoid and Opportunities Ahead

  Moderator

  David Heaney,

  Chief Information Security Officer, Mass General Brigham

  Speakers

  Rich Adduci,

  Operating Partner, Berkshire Partners

  Nancy Cam-Winget,

  Cisco Fellow, Cisco Systems

  Tal Liani,

  Data Networking and Networking Security Analyst, BofA Securities

  Ariel Stern, PhD,

  Alexander von Humboldt Professor, Hasso Plattner Institute

• 09:10 AM - 09:50 AM

  Beyond Opioids | Existing Therapies and Innovations in Pain Management

  Moderator

  Robert Edwards, PhD,

  Clinical Psychologist, Pain Management Center, Brigham and Women’s Hospital;

  Associate Professor of Anesthesia, Harvard Medical School

  Speakers

  Roman Camarda,

  Principal, Novo Holdings Venture Investments

  Lilit Garibyan, MD, PhD

  Physician-Scientist, Wellman Center for Photomedicine, MGH;

  Associate Professor of Dermatology, HMS

  Paul Negulescu, PhD,

  Senior Vice President and Disease Area Executive for Pain, Vertex

• 09:10 AM - 09:50 AM

  Xenotransplant | The Clinical Reality Emerges

  Moderator

  Leonardo Riella, MD, PhD

  Medical Director of Kidney Transplantation, Massachusetts General Hospital;

  Harold and Ellen Danser Endowed Chair in Transplantation, Harvard Medical School

  Speakers

  Mike Curtis,

  President & CEO, eGenesis

  Pablo Legorreta,

  Founder, CEO & Chairman, Royalty Pharma

  Julie Sunderland,

  Founder & President, Oriane Consulting

• 09:10 AM - 09:50 AM

  Gene Editing | Precision Medicine in Practice

  Moderator

  Benjamin Kleinstiver, PhD,

  Investigator, Center for Genomic Medicine; Kayden-Lambert MGH Research Scholar 2023-2028, Mass General Brigham;

  Associate Professor of Pathology, Harvard Medical School

  Speakers

  Omar Abudayyeh, PhD,

  Director of Gene Editing, Gene and Cell Therapy Institute, Mass General Brigham;

  Assistant Professor of Medicine, Harvard Medical School

  Steve Favaloro

  Chairman & CEO, Genezen

  David Liu, PhD

  Richard Merkin Professor; Director, Merkin Institute of Transformative Technologies in Healthcare, Broad Institute

  Laura Sepp-Lorenzino, PhD

  Executive Vice President, Chief Scientific Officer, Intellia Therapeutics

• 09:10 AM - 09:50 AM

  Emerging Treatments

  Emerging Treatments | Cardiovascular Disease

  Moderators

  Tazeen Ahmad

  Managing Director, Global Research, BofA Securities

  Tim Anderson, MD,

  Pharmaceutical Analyst, BofA Securities

  Speakers

  Brian Bergmark, MD,

  Interventional Cardiologist, Brigham and Women’s Hospital;

  Assistant Professor of Medicine, Harvard Medical School

  Erin Bohula, MD, DPhil,

  Cardiologist, TIMI Study Group, Brigham and Women’s Hospital;

  Assistant Professor of Medicine, Harvard Medical School

  Calum MacRae, MD, PhD

  Vice Chair for Scientific Innovation, Department of Medicine, Brigham and Women's Hospital;

  Professor of Medicine, Harvard Medical School

  Pradeep Natarajan, MD

  Director of Preventive Cardiology, Paul & Phyllis Fireman Endowed Chair in Vascular Medicine, Massachusetts General Hospital;

  Associate Professor of Medicine, Harvard Medical School